DEUTSCHE BANK AG\ - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 209 filers reported holding BRIDGEBIO PHARMA INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$5,307,648
+13.3%
201,276
-26.1%
0.00%
+50.0%
Q2 2023$4,683,165
-27.2%
272,277
-29.8%
0.00%
-50.0%
Q1 2023$6,434,465
+195.1%
388,086
+35.6%
0.00%
+300.0%
Q4 2022$2,180,448
+15.4%
286,148
+50.6%
0.00%0.0%
Q3 2022$1,889,000
+93.0%
190,034
+76.1%
0.00%0.0%
Q2 2022$979,000
+47.9%
107,895
+65.6%
0.00%
Q1 2022$662,000
-43.0%
65,166
-6.4%
0.00%
-100.0%
Q4 2021$1,161,000
-70.6%
69,589
-17.5%
0.00%
-50.0%
Q3 2021$3,951,000
-80.2%
84,311
-74.2%
0.00%
-80.0%
Q2 2021$19,938,000
-38.6%
327,062
-37.9%
0.01%
-41.2%
Q1 2021$32,448,000
+739.3%
526,760
+868.8%
0.02%
+750.0%
Q4 2020$3,866,000
+158.9%
54,370
+36.7%
0.00%
+100.0%
Q3 2020$1,493,000
+9.1%
39,785
-5.2%
0.00%0.0%
Q2 2020$1,368,000
+81.2%
41,956
+61.0%
0.00%0.0%
Q1 2020$755,000
+166.8%
26,053
+221.6%
0.00%
Q4 2019$283,000
+105.1%
8,101
+24.1%
0.00%
Q3 2019$138,0006,5270.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders